The Ocular Immunology and Uveitis Foundation

Articles Published by the Ocular Immunology and Uveitis Foundation

C. Stephen Foster, M.D.

 

In Print (551-600)

Previous 50      Next 50

551. Management of anterior uveitis: Immunomodulatory Therapy is gaining acceptance.    Fortuna ES, Hinkle D, Foster CS. Ophthalmology Management 2006;October; 61-101.  No abstract available.  

552. Conjunctival non-caseating granulomas in a human immunodeficiency virus (HIV) positive patient attributed to sarcoidosis.Abstract Papadaki TG, Kafkala C, Zacharopoulos IP, Seyedahmadi B J, Dryja T, Foster CS Ocul Immunol Inflamm. 2006;14(5):309-11.  

553. Mooren ulcer: An immunopathologic study.   Abstract Kafkala C, Choi J, Zafirakis P, Baltatzis S, Livir-Rallatos C, Rojas B, Foster CS. Cornea. 2006 Jul;25(6):667-73.  

554. Chronic cicatrizing conjunctivitis in a patient with epidermolysis bullosa acquisita.   Abstract Letko E, Bhol K, Anzaar F, Perez VL, Ahmed AR, Foster CS. Arch Ophthalmol. 2006 Nov;124(11):1615-1618.  

555. Plasmapheresis for lupus retinal vasculitis.    Abstract Papadaki TG, Zacharopoulos IP, Papaliodis G, Iaccheri B, Fiore T, Foster CS. Arch Ophthalmol. 2006 Nov;124(11):1654-6.  

556. PImmunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy.    Abstract Paredes I, Ahmed M, Foster CS. Ocul Immunol Inflamm. 2006 Apr;14(2):87-90.  

557 Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema..   Abstract Androudi S, Letko E, Meniconi M, Papadaki T, Ahmed M, Foster CS. Ocul Immunol Inflamm. 2005 Apr-Jun;13(2-3):205-12.  



558. Octreotide as a treatment for uveitic cystoid macular edema.     Kafkala C, Choi JY, Choopong P, Foster CS. Arch Ophthalmol. 2006 Sep;124(9):1353-5. No abstract available.  
 

559. CSolitary myofibroma of the sclera Abstract Choopong P, Nielsen PG, Perlman EM, Huang JJ, Dryja TP, Foster CS. Cornea. 2007 Jan;26(1):114-6.

560. Presumed oculoglandular syndrome from Bartonella quintana.Abstract Borboli S, Afshari NA, Watkins L, Foster CS. Ocul Immunol Inflamm. 2007 Jan-Feb;15(1):41-3.
 

561.Sclerokeratitis and facial skin lesions: A case report of pyoderma gangrenosum and its response to dapsone therapy.Abstract Teasley LA, Foster CS, Baltatzis S Cornea. 2007 Feb;26(2):215-219.
 

562. Intravitreal bevacizumab fortreatment of uveitic macular edema. Abstract Cordero Coma M, Sobrin L, Onal S, Christen W, Foster CS. Ophthalmology. 2007 Mar 14.
 

563. Punctate inner choroidopathy: A survey analysis of 77 persons Abstract Gerstenblith AT, Thorne JE, Sobrin L, Do DV, Shah SM, Foster CS, Jabs DA, Nguyen QD.Ophthalmology. 2007 Apr 13.
 

564. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation Abstract Cordero-Coma M, Anzaar F, Sobrin L, Foster CS. Ocul Immunol Inflamm. 2007 Mar-Apr;15(2):99-104.
 

565. Biologic response modifier therapy for refractory childhood uveitis. Abstract Gallagher MJ, Quinones K, Cervantes-Castaneda RA, Yilmaz T, Foster CS. Br J Ophthalmol. 2007 Jun 7; 
 


566. Syphilis: An ophthalmologic update. No abstract Teasley LA, Foster CS. Int Ophthalmol Clin. 2007 Spring;47(2):133-44. Review. No abstract available
 

567. Adamantiades-Bechet disease: diagnosis and current concepts in management of ocular manifestations. Abstract Gerstenblith AT, Thorne JE, Sobrin L, Do DV, Shah SM, Foster CS, Jabs DA, Nguyen QD. Compr Ophthalmol Update. 2007 Jul-Aug;8(4):225-33. Review
 

568. Intravitreal clindamycin for toxoplasmic retinochoroiditis. Abstract Sobrin L, Kump LI, Foster CS. Retina. 2007 Sep;27(7):952-7.
 

569. Relative risk for cancer in mucous membrane pemphigoid associated with antibodies to the beta4 integrin subunit. Abstract Letko E, Gürcan HM, Papaliodis GN, Christen W, Foster CS, Ahmed AR. Clin Exp Dermatol. 2007 Nov;32(6):637-41. Epub 2007 May 25.  
 

570. The characteristic features of optical coherence tomography in posterior uveitis. Abstract Gallagher MJ, Yilmaz T,  Cervantes-Castañeda RA, Foster CS. Br J Ophthalmol. 2007 Dec;91(12):1680-5. Epub 2007 Jun 25. Review. 

 

571. Coma MC, Yilmaz T, Foster CS. Abstract Tumour necrosis factor-alpha in conjunctivae affected by ocular cicatricial pemphigoid. Acta Ophthalmol Scand. 2007 Nov;85(7):753-5. Epub 2007 May 4.


572. The Boston Keratoprosthesis in Stevens-Johnson Syndrome. Abstract Sayegh RR, Ang LP, Foster CS, Dohlman CH. Am J Ophthalmol. 2008 Jan 18.

 

573. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Abstract Kempen JH, Daniel E, Gangaputra S, Dreger K, Jabs DA, Kaçmaz RO, Pujari SS, Anzaar F, Foster CS, Helzlsouer KJ, Levy-Clarke GA, Nussenblatt RB, Liesegang T, Rosenbaum JT, Suhler EB. Ophthalmic Epidemiol. 2008 Jan-Feb;15(1):47-55.
 

574. Daclizumab for treatment of birdshot chorioretinopathy. Free Full Text Sobrin L, Huang JJ, Christen W, Kafkala C, Choopong P, Foster CS. Arch Ophthalmol. 2008 Feb;126(2):186-91.  
 

575. Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation. Abstract Ahmed M, Niffenegger JH, Jakobiec FA, Ben-Arie-Weintrob Y, Gion N, Androudi S, Folberg R, Raizman MB, Margo CE, Smith ME, McLean IW, Caya JG, Foster CS.

Int Ophthalmol. 2008 Feb;28(1):35-46. Epub 2007 Jun 23.
 

576. Tubulointerstitial nephritis and uveitis syndrome. Abstract Hinkle DM, Foster CS.. Int Ophthalmol Clin. 2008 Spring;48(2):9-13. 


577. Cataract surgery in children with juvenile idiopathic arthritis associated uveitis. Abstract Acevedo S, Quinones K, Rao V, Cervantes-Castañeda RA, Foster CS. Int Ophthalmol Clin. 2008 Spring;48(2):1-7. No abstract available.
 

 

578. Long-term Risk of Malignancy Among Patients Treated With Immunosuppressive Agents for Ocular Inflammation: A Critical Assessment of the Evidence. Abstract Kempen JH, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Helzlsouer KJ. Am J Ophthalmol. 2008 Jun 23;
 

 

579. Biologic response modifier therapy for psoriatic ocular inflammatory disease. Abstract Huynh N, Cervantes-Castaneda RA, Bhat P, Gallagher MJ, Foster CS. 2008 May-Ocul Immunol InflammJun;16(3):89-93.
 

 

580. Primary intraocular lymphoma: Another great masquerader. Abstract Gallagher MJ, Cervantes-Castaneda RC, Bhat P, Yilmaz T, Foster CS. Eur J Ophthalmol. 2008 Jul-Aug;18(4):567-71.
 

 

581. Subconjunctival bevacizumab for corneal neovascularization. Abstract Doctor PP, Bhat PV, Foster CS. Cornea. 2008 Oct;27(9):992-5.
 

 

582. Induction of durable remission in ocular inflammatory diseases. Abstract Cervantes-Castaneda RA, Bhat P, Fortuna E, Acevedo S, Foster CS.  Eur J Ophthalmol. 2009 Jan-Feb;19(1):118-23.
 

 

583. Intravenous daclizumab for recalcitrant ocular inflammatory disease Abstract Bhat P, Castañeda-Cervantes RA, Doctor PP, Foster CS. Graefes Arch Clin Exp Ophthalmol. 2009 Feb 6.
 

 

584. Outcomes of cataract surgery in children with chronic uveitis. Abstract Quiñones K, Cervantes-Castañeda RA, Hynes AY, Daoud YJ, Foster CS. J Cataract Refract Surg. 2009 Apr;35(4):725-31.
 

 

585. Conjunctival/corneal intraepithelial neoplasia. No abstract Hamam R, Bhat P, Foster CS. Int Ophthalmol Clin. 2009 Winter;49(1):63-70. Review. No abstract available.

 

 586. Serum soluble interleukin-2 receptor levels do not correlate with an associated systemic disease in patients with uveitis.  Abstract Papadaki T, Iaccheri B, Fiore T, Zacharopoulos I, Thadani S, Christen W, Androudi S, Foster CS. Acta Ophthalmol. 2009 Jun 2.

 

587. Acute Posterior Multifocal Placoid Pigment Epitheliopathy: Outcome and Visual Prognosis.  Abstract Fiore T, Iaccheri B, Androudi S, Papadaki TG, Anzaar F, Brazitikos P, D'Amico DJ, Foster CS. Retina. 2009 May 27.

 

588. Vogt-Koyanagi-Harada syndrome associated with bilateral serous macular detachments responsive to immunomodulatory therapy.  Abstract Gallagher MJ, Yilmaz T, Foster CS. Ophthalmic Surg Lasers Imaging. 2009 May-Jun;40(3):345-7.
 

589. Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment.  Abstract Mauro J, Foster CS. Semin Ophthalmol. 2009 May-Jun;24(3):130-4.
 

590. Intravitreal bevacizumab for uveitic choroidal neovascularization.  Abstract Doctor PP, Bhat P, Sayed R, Foster CS. Ocul Immunol Inflamm. 2009 Mar-Apr;17(2):118-26.
 

591. Intravenous daclizumab for recalcitrant ocular inflammatory disease.  Abstract Bhat P, Castañeda-Cervantes RA, Doctor PP, Foster CS. Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):687-92. Epub 2009 Feb 6.
 

592. Chronic Herpes Simplex Scleritis: Characterization of 9 Cases of an Underrecognized Clinical Entity. Abstract  Bhat PV, Jakobiec FA, Kurbanyan K, Zhao T, Foster CS. Am J Ophthalmol. 2009 Aug 10.


593. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. AbstractBhat P, Cervantes-Castañeda RA, Doctor PP, Anzaar F, Foster CS. Ocul Immunol Inflamm. 2009 May-Jun;17(3):185-90.   


594. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. AbstractKempen JH, Daniel E, Dunn JP, Foster CS, Gangaputra S, Hanish A, Helzlsouer KJ, Jabs DA, Kaçmaz RO, Levy-Clarke GA, Liesegang TL, Newcomb CW, Nussenblatt RB, Pujari SS, Rosenbaum JT, Suhler EB, Thorne JE.BMJ. 2009 Jul 3;339:b2480. doi: 10.1136/bmj.b2480. 

595. Intravitreal bevacizumab for uveitic choroidal neovascularization. AbstractDoctor PP, Bhat P, Sayed R, Foster CS.Ocul Immunol Inflamm. 2009 Mar-Apr;17(2):118-26. 

 

596. Methotrexate for ocular inflammatory diseases.  Gangaputra S, Newcomb CW, Liesegang TL, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Ophthalmology. 2009 Nov;116(11):2188-98.e1. Epub 2009 Sep 12.

 

597. Foster CS.  Treatment of herpes simplex keratitis.  Refractive Eyecare.  2009 Jan; 13(1).

 

598. Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up. Cervantes-Castañeda RA, Giuliari GP, Gallagher MJ, Yilmaz T, MacDonell RE, Quinones K, Foster CS. Eur J Ophthalmol. 2009 Jul-Aug;19(4):622-9.

 

599. Foster CS.  Vernal and Atopic Keratoconjunctivitis.  Refractive Eyecare.  2009 Jun 13(6).

 

600. Khan FH, Quinones K,  Foster CS.  Ocular Allergy. Contemporary Ophthalmology. 2009 Jul 30; 8(14): 1-8.

Previous 50      Next 50